Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$76.74 - $85.2 $4,834 - $5,367
63 Added 1.25%
5,087 $392,000
Q2 2023

Aug 11, 2023

SELL
$69.16 - $82.11 $550,375 - $653,431
-7,958 Reduced 61.3%
5,024 $412,000
Q1 2023

May 12, 2023

BUY
$64.46 - $77.23 $19,466 - $23,323
302 Added 2.38%
12,982 $915,000
Q4 2022

Feb 10, 2023

SELL
$56.51 - $71.71 $5,311 - $6,740
-94 Reduced 0.74%
12,680 $868,000
Q3 2022

Nov 10, 2022

SELL
$56.96 - $78.09 $16.4 Million - $22.4 Million
-287,289 Reduced 95.74%
12,774 $752,000
Q2 2022

Aug 12, 2022

BUY
$64.25 - $81.25 $19.3 Million - $24.4 Million
300,063 New
300,063 $20.9 Million

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $41B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.